Skip to Content


In the US, Rasagiline (rasagiline systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of Parkinson's disease

Inhibitor of monoamin oxidase type B (MAO-B)

Chemical Names



Foreign Names

  • Rasagilinum (Latin)
  • Rasagilin (German)
  • Rasagiline (French)
  • Rasagilina (Spanish)

Generic Names

  • Rasagiline (OS: USAN)
  • Rasagiline Mesylate (OS: USAN)
  • AGN-1135 (IS)
  • Rasagiline methanesulfonate (IS)
  • TVP 1012 (IS: Teva)
  • TVP-101 (IS)

Brand Names

  • Azilect
    Lundbeck, Denmark; Lundbeck, Latvia; Lundbeck, Turkey; Teva, Slovakia; Teva Pharmaceuticals, Poland
  • Parkintreat
    Inspire Ph, Egypt
  • Ralago
    KRKA, Slovenia
  • Rangar
    Productos Farmaceuticos Medipharm, Chile
  • Rasagiline Amneal
    Amneal, Netherlands
  • Rasagiline Aurobindo
    Aurobindo, Netherlands
  • Rasagiline BioOrganics
    BioOrganics, Netherlands
  • Rasagiline CF
    Centrafarm, Netherlands
  • Rasagiline DOC Generici
    DOC Generici, Netherlands
  • Rasagiline Genericon
    Genericon, Netherlands
  • Rasagiline Genthon
    Genthon, Netherlands
  • Rasagiline Krka
    Krka, Netherlands
  • Rasagiline Sandoz
    Sandoz, Netherlands
  • Rasagiline Synthon
    Synthon, Netherlands
  • Rasalin
    Vianex, Netherlands
  • Rasax
    AstraZeneca, Argentina
  • Agilect
    Teva, United States
  • Azilect
    Lundbeck, Australia; Lundbeck, Belgium; Lundbeck, Spain; Lundbeck, Finland; Lundbeck, France; Lundbeck, Croatia (Hrvatska); Lundbeck, Ireland; Lundbeck, Sweden; Lundbeck, Thailand; Lundbeck, South Africa; Lundbeck Italia, Italy; Teva, Austria; Teva, Czech Republic; Teva, Greece; Teva, Hungary; Teva, Israel; Teva, Iceland; Teva, Lithuania; Teva, Mexico; Teva, Norway; Teva, Romania; Teva, Serbia; Teva, United States; Teva Canada Innovation, Canada; Teva Pharma, Switzerland; Teva Pharma, Cyprus; Teva Pharma, Germany; Teva Pharma, Portugal; Teva Pharmaceuticals, United Kingdom
  • Elbrus
    Laboratorios Raffo, Chile; Roemmers, Argentina
  • Menuix
    Pharma Investi de Chile, Chile; Roemmers Centroamérica, Guatemala; Roemmers Centroamérica, Honduras; Roemmers Centroamérica, Nicaragua; Roemmers Centroamérica, Panama; Roemmers Centroamérica, El Salvador
  • Rasagilina Richet
    Richet, Argentina
  • Rasagilin-Mepha
    Mepha Pharma, Switzerland


ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.